Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Fibroblasts help understand androgen resistance at the cellular level.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Spironolactone may help reduce hair loss in androgenic alopecia.

Women with PCOS often have more sleep problems than the general population.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Moderately high prolactin levels do not cause hair loss in women.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.